BIODESIX, INC. Total Liabilities
BIODESIX, INC. (BDSX) had Total Liabilities of $86.18 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-05
- 2026-06-30: Liabilities $86.18M.
- 2026-03-31: Liabilities $85.50M.
- 2025-12-31: Liabilities $89.94M.
- 2025-09-30: Liabilities $90.44M.
| Period end | Liabilities |
|---|---|
| 2026-06-30 | $86.18M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $85.50M 10-Q · filed 2026-05-04 |
| 2025-12-31 | $89.94M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $90.44M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $86.60M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $75.18M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $76.37M 10-K · filed 2026-02-26 |
| 2024-09-30 | $74.89M 10-Q · filed 2024-11-01 |
| 2024-06-30 | $79.58M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $92.70M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $94.52M 10-K · filed 2025-03-03 |
| 2023-09-30 | $88.23M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $84.62M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $76.24M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $72.30M 10-K · filed 2024-03-01 |
| 2022-09-30 | $66.10M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $67.56M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $53.87M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $56.37M 10-K · filed 2023-03-06 |
| 2021-09-30 | $73.96M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $76.03M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $79.05M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $79.90M 10-K · filed 2022-03-14 |
| 2020-09-30 | $107.76M 10-Q · filed 2020-12-10 |
| 2019-12-31 | $76.21M 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |